Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma
NCT01182142Phase 2Completed
- Start
- Sep 2007
- Primary completion
- Sep 2009
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in non-clear cell renal cell carcinoma (nccRCC). Started Sep 2007; status: completed.
02
Drugs
capecitabine
03
Conditions
non-clear cell renal cell carcinoma (nccRCC)
Beyond the preview
Go deeper on NCT01182142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01182142.